Other GLP-1 agonist drugs for diabetes, including Mounjaro (tirzepatide), have similar benefits
Ask at your consultation or call for current pricing
When combined with GLP-1, it appears to enhance glucose control and may improve tolerability, allowing higher therapeutic doses with fewer gastrointestinal side effects in many people
Rather than asking whether metformin should stay or go, clinicians should focus on how best to tailor therapy to individual patient needs
Pierre-Louis: And since 2021, when Wegovy was approved for weight loss, weve seen sort of this explosion in GLP-1stheres tirzepatide, liraglutide, dulaglutide
United States Belzutifan (Welireg) United Kingdom Pembrolizumab (Keytruda) Australia Teplizumab (Tzield) Canada Sotorasib (Lumakras) South Korea Eptinezumab (Vyepti) New Zealand Tislelizumab (Tevimbra) These therapies reflect the growing focus on precision medicine, immunotherapy, and patient-centric innovation while highlighting the importance of understanding safety considerations and market trends
